Comprehensive mutational profiling of core binding factor acute myeloid leukemia. - Test2 - elhamkhani - TriplyDB

Comprehensive mutational profiling of core binding factor acute myeloid leukemia.

Comprehensive mutational profiling of core binding factor acute myeloid leukemia.

http://www.wikidata.org/entity/Q33758306

about

Molecular Basis and Targeted Inhibition of CBFβ-SMMHC Acute Myeloid Leukemia.ASXL2 is essential for haematopoiesis and acts as a haploinsufficient tumour suppressor in leukemia.Mutations in the CCND1 and CCND2 genes are frequent events in adult patients with t(8;21)(q22;q22) acute myeloid leukemia The genomic landscape of core-binding factor acute myeloid leukemias Diagnosis and management of AML in adults: 2017 ELN recommendations from an international expert panel.The mutational oncoprint of recurrent cytogenetic abnormalities in adult patients with de novo acute myeloid leukemia.Clinical Relevance of RUNX1 and CBFB Alterations in Acute Myeloid Leukemia and Other Hematological Disorders.The Role of Additional Sex Combs-Like Proteins in Cancer.Myelodysplastic syndromes and acute leukemia with genetic predispositions: a new challenge for hematologists.Diagnosis and classification of hematologic malignancies on the basis of genetics.Cohesin Mutations in Myeloid Malignancies.Fludarabine and cytarabine versus high-dose cytarabine in consolidation treatment of t(8; 21) acute myeloid leukemia: A prospective, randomized study.Next-generation sequencing with a myeloid gene panel in core-binding factor AML showed KIT activation loop and TET2 mutations predictive of outcome.D816 mutation of the KIT gene in core binding factor acute myeloid leukemia is associated with poorer prognosis than other KIT gene mutations.Prognostic impacts and dynamic changes of cohesin complex gene mutations in de novo acute myeloid leukemia.ASXL2 mutations are frequently found in pediatric AML patients with t(8;21)/ RUNX1-RUNX1T1 and associated with a better prognosis.SNP-array lesions in core binding factor acute myeloid leukemia.Genotypic and clinical heterogeneity within NCCN favorable-risk acute myeloid leukemia.Concomitant BCORL1 and BRAF Mutations in Vemurafenib-Resistant Melanoma Cells.Preleukemia and Leukemia-Initiating Cell Activity in inv(16) Acute Myeloid Leukemia.Mutational spectrum of acute myeloid leukemia patients with double CEBPA mutations based on next-generation sequencing and its prognostic significance.Core-binding factor acute myeloid leukemia with t(8;21): Risk factors and a novel scoring system (I-CBFit)Heterogeneous prognosis among KIT mutation types in adult acute myeloid leukemia patients with t(8;21)When to obtain genomic data in acute myeloid leukemia (AML) and which mutations matter

P2860

Q30252938-1C6ED31B-1751-4633-A24A-6296FDF03417 Q33753763-437E8C51-8CB3-43C7-99DC-17C1E9FB3F47 Q33774508-70AD52C1-A1F9-4D18-9EBF-93FE1E9C0546 Q33901968-622FDCA1-6FC5-4F3D-AE8F-E6E4A637FCAC Q37624593-D8D071A7-4520-4605-B87C-D1605421FD7D Q38892311-B1D5D64A-9BAE-4C05-ACB9-6678FF053BD3 Q38904250-7A1A9E04-EA91-4DFB-9686-0B44F7DAF885 Q38928350-9CAC5CCB-534E-404D-ABD6-FF13A717E110 Q39000607-A660CA79-BFC2-49EC-9ACC-2D9AFBC2F6BF Q39363409-175A6789-A29F-4F61-A7CD-434766336BB8 Q39381849-30334C65-D525-4341-B1B5-07D2706519B9 Q40528087-06A3E722-56C8-4C65-B09E-49F42D33C3C1 Q41138171-BC49BAC7-08E3-4B8B-B4EC-41209514551C Q48005752-D82A1ACE-83CA-4E68-992F-DF0028FCD0BD Q48330013-39714CF7-1D54-4182-9648-E464554E7DD4 Q48375295-F8B9D5B3-CBC2-4842-8730-355C05E00624 Q50014393-07A798DD-0129-4528-B0C4-DCBB685B91A1 Q50137311-F87A38AF-16F0-4CAF-BFE0-3FEFE811D161 Q52335475-EF8ACC02-8BF8-4C02-8D99-D8909556553B Q53821842-E3FDB9B7-E6DE-42A1-AF6C-86452D3BB7CF Q55020301-2D267BAA-9A7E-4B41-A7F3-E5774D7A3C99 Q58772579-CC57A69B-F54E-4063-8CA1-84502C14A52A Q58797772-8FBAF070-D88C-4E13-B7F4-53C807B3359D Q59133388-173FF7A6-B890-46FC-A0D8-38D4DCA16B7F

P2860

Comprehensive mutational profiling of core binding factor acute myeloid leukemia.

http://www.wikidata.org/entity/Q33758306

description

2016 nî lūn-bûn

@nan

2016 թուականի Մարտին հրատարակուած գիտական յօդուած

@hyw

2016 թվականի մարտին հրատարակված գիտական հոդված

@hy

2016年の論文

@ja

2016年学术文章

@wuu

2016年学术文章

@zh-cn

2016年学术文章

@zh-hans

2016年学术文章

@zh-my

2016年学术文章

@zh-sg

2016年學術文章

@yue

name

Comprehensive mutational profiling of core binding factor acute myeloid leukemia.

@ast

Comprehensive mutational profiling of core binding factor acute myeloid leukemia.

@en

type

label

Comprehensive mutational profiling of core binding factor acute myeloid leukemia.

@ast

Comprehensive mutational profiling of core binding factor acute myeloid leukemia.

@en

prefLabel

Comprehensive mutational profiling of core binding factor acute myeloid leukemia.

@ast

Comprehensive mutational profiling of core binding factor acute myeloid leukemia.

@en

P1433

Q33758306-278D8777-9773-4661-B9A5-53EEEFD9B600

P1476

Q33758306-7ADD576D-1E95-4832-ABAE-84A69D059776

P2093

Q33758306-2CCE7A82-45E6-43DE-BE54-66996B97D395

Q33758306-2FED1875-80A2-415C-B6B8-E63A2A4798DA

Q33758306-3BD25736-23BC-4144-8E54-3F5BD358AA22

Q33758306-450341D7-85D0-4D76-B8A0-118130E3ED75

Q33758306-4677DD19-DF71-4212-98DD-104EBCF1B65A

Q33758306-48CE687A-9DF3-49EA-9241-EA04C67D0058

Q33758306-54848213-6C5A-4D5D-B336-7B0116F37832

Q33758306-5E40E3C6-06BC-435E-93AE-D36260116E36

Q33758306-760EA949-9AE5-4F40-9B0E-35331975D73F

Q33758306-76A8C6BE-4009-4271-89BE-86C7D5E63A20

P2860

Q33758306-015DFA7A-5E52-4ED5-898F-8B62B50052A2

Q33758306-02BD18A5-348B-4A46-AAC2-C7B76EEB7696

Q33758306-07275294-7A2C-4746-8369-FC25C6EFE365

Q33758306-0E838C06-33A2-4582-A130-2F13D77714C6

Q33758306-0F0AB17E-537E-48EE-ACA7-DB1A499BC3A6

Q33758306-193A99AE-452C-4686-81F1-39157A86D225

Q33758306-1CA693D9-BCD6-43F0-B23C-451A1B07124C

Q33758306-24810563-4383-435C-9E16-CA700340AED2

Q33758306-2F2ABF5D-2B83-4517-845F-D9D4ABCE3ECC

Q33758306-2FDF8AFF-2ACB-4094-8132-11AFE2A2D249

P304

Q33758306-BB7DDBD0-67D6-4200-BD0A-09393FD94C37

P31

Q33758306-30EF827F-1389-4B95-9470-B2D4AAC0A8FD

P356

Q33758306-14F0FAF6-7642-44F2-BB2B-64468186F0B6

P407

Q33758306-AB6D8C20-4E6C-4F7C-8478-46AC1275C840

P433

Q33758306-031DB591-F7F7-4757-9D0C-CDB2B900A03C

P478

Q33758306-F4231820-D3EB-4FD9-96FD-ADDF62193A4E

P50

Q33758306-1F5056B4-F7FB-40B2-86A8-11407E6B7808

Q33758306-63C7D911-8F08-4512-90F8-895BBB6AE319

Q33758306-63D26255-B129-49B6-AC9A-616DB1A33E99

Q33758306-69D1DE28-F558-49CD-A87E-E6133DBBE0D4

Q33758306-7CBF1CED-7F3B-4111-A7B2-C3C1F61A8236

Q33758306-9DE68974-1DC5-472A-A576-ED2709703FDF

P577

Q33758306-995E05DD-22B8-4589-AFDB-D352324D9952

P698

Q33758306-04A8340A-C0F7-4020-B1E6-6DE2910FCED8

P921

Q33758306-B69DEAD1-B52C-4D4E-AA78-9A477282264A

P932

Q33758306-CCB8C803-C095-44C8-907D-6F750E517ADD

P356

BLOOD-2015-12-688705

P1433

P1476

Comprehensive mutational profiling of core binding factor acute myeloid leukemia.

@en

P2093

Aline Renneville

http://www.w3.org/2001/XMLSchema#string

Catherine Lacombe

http://www.w3.org/2001/XMLSchema#string

Christine Ragu

http://www.w3.org/2001/XMLSchema#string

Eric Jourdan

http://www.w3.org/2001/XMLSchema#string

Guy Leverger

http://www.w3.org/2001/XMLSchema#string

Hervé Dombret

http://www.w3.org/2001/XMLSchema#string

Hélène Lapillonne

http://www.w3.org/2001/XMLSchema#string

Jean-Baptiste Micol

http://www.w3.org/2001/XMLSchema#string

Karine Celli-Lebras

http://www.w3.org/2001/XMLSchema#string

Maxime Bucci

http://www.w3.org/2001/XMLSchema#string

P2860

Structure of the Catalytic Domain of EZH2 Reveals Conformational Plasticity in Cofactor and Substrate Binding Sites and Explains Oncogenic Mutations

Diagnosis and management of acute myeloid leukemia in adults: recommendations from an international expert panel, on behalf of the European LeukemiaNet

Genomic and epigenomic landscapes of adult de novo acute myeloid leukemia.

Individual patient data-based meta-analysis of patients aged 16 to 60 years with core binding factor acute myeloid leukemia: a survey of the German Acute Myeloid Leukemia Intergroup.

Prevalence and prognostic significance of KIT mutations in pediatric patients with core binding factor AML enrolled on serial pediatric cooperative trials for de novo AML.

Acute myeloid leukemias with reciprocal rearrangements can be distinguished by specific gene expression profiles

ASXL genes and RUNX1: an intimate connection?

Frequent ASXL2 mutations in acute myeloid leukemia patients with t(8;21)/RUNX1-RUNX1T1 chromosomal translocations.

Modeling interactions between leukemia-specific chromosomal changes, somatic mutations, and gene expression patterns during progression of core-binding factor leukemias

Genetic alterations of the cohesin complex genes in myeloid malignancies.

P304

2451-2459

http://www.w3.org/2001/XMLSchema#string

P31

scholarly article

P356

10.1182/BLOOD-2015-12-688705

http://www.w3.org/2001/XMLSchema#string

P407

P433

20

http://www.w3.org/2001/XMLSchema#string

P478

127

http://www.w3.org/2001/XMLSchema#string

P50

Claude Preudhomme

Nicolas Duployez

Alice Marceau-Renaut

P577

2016-03-15T00:00:00Z

http://www.w3.org/2001/XMLSchema#dateTime

P698

26980726

http://www.w3.org/2001/XMLSchema#string

P921

P932

5457131

http://www.w3.org/2001/XMLSchema#string